Vitamin D Deficiency and Acute Vaso-occlusive Complications in Children With Sickle Cell Disease

被引:24
|
作者
Lee, Margaret T. [1 ]
Licursi, Maureen [1 ]
McMahon, Donald J. [2 ]
机构
[1] Columbia Univ, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol Stem Cell Transplantat, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Dept Med, Div Endocrinol, New York, NY 10032 USA
关键词
sickle cell disease; vitamin D; pain; acute chest syndrome; CHRONIC PAIN; D THERAPY; ANEMIA; INFLUENZA; HEALTH; ASTHMA;
D O I
10.1002/pbc.25399
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundVitamin D is increasingly recognized for its roles in non-skeletal disorders. Patients with sickle cell disease (SCD) have a high prevalence of vitamin D deficiency but data are limited with respect to possible associations between low vitamin D and acute vaso-occlusive complications. We examined whether vitamin D deficiency is associated with acute pain and acute chest syndrome (ACS) in children with SCD. ProcedureA cross-sectional study was conducted in 95 children with SCD who had serum 25-hydroxyvitamin D (25-OHD) measured during comprehensive care examinations. History of acute pain and ACS within two years of obtaining 25-OHD was collected. Associations between 25-OHD levels and acute vaso-occlusive events were analyzed by logistic regression. Odds ratios and 95% confidence intervals were calculated for the risk of pain and ACS associated with vitamin D deficiency (25-OHD <20ng/ml). ResultsSubjects were 3-20 years old (median 10.6); 48 males, 47 females; 46 African, 49 Hispanic; 72 SS, 20 SC, 1 S/(0)Thalassemia, and 2 S/(+)Thalassemia. Median 25-OHD was 16ng/ml. Fifty-six (59%) were vitamin D-deficient. Thirty-one (33%) and 29 (31%) had at least one episode of pain and ACS, respectively. Serum 25-OHD was significantly associated with pain (P=0.0121) but not with ACS (P=0.628). Of those with pain, 73% (23/31) were vitamin D-deficient while 26% (8/31) had 25-OHD 20ng/ml (P=0.04, OR=2.7, 95%CI=1.05-6.94). ConclusionsOur findings emphasize the high prevalence of vitamin D deficiency and its potential association with acute pain in SCD. Correcting low vitamin D may offer a simple, low-cost intervention to help reduce acute vaso-occlusive complications. Pediatr Blood Cancer 2015;62:643-647. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 50 条
  • [1] VITAMIN D DEFICIENCY AND RISK OF ACUTE VASO-OCCLUSIVE COMPLICATIONS IN CHILDREN WITH SICKLE-CELL DISEASE
    Lee, Margaret
    Licursi, Maureen
    McMahon, Donald
    Brittenham, Gary
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : S23 - S23
  • [2] Management of vaso-occlusive pain in children with sickle cell disease
    Jacob, E
    Miaskowski, C
    Savedra, M
    Beyer, JE
    Treadwell, M
    Styles, L
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (04) : 307 - 311
  • [3] Sickle cell disease in children: Osteomyelitis or vaso-occlusive crises?
    Berger, Elizabeth
    Saunders, Natasha
    Khambalia, Amina
    Friedman, Jeremy N.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 612 - 612
  • [4] ACUTE MANAGEMENT OF VASO-OCCLUSIVE PAIN IN PEDIATRIC SICKLE CELL DISEASE
    Freed, Jennifer
    Ender, Katherine L.
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 727 - 727
  • [5] Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia
    Quinn, Charles T.
    Shull, Elizabeth P.
    Ahmad, Naveed
    Lee, Nancy J.
    Rogers, Zora R.
    Buchanan, George R.
    [J]. BLOOD, 2007, 109 (01) : 40 - 45
  • [6] Blood pressure in acute vaso-occlusive crises of sickle cell disease
    Ernst, AA
    Weiss, SJ
    Johnson, WD
    Takakuwa, KM
    [J]. SOUTHERN MEDICAL JOURNAL, 2000, 93 (06) : 590 - 592
  • [7] Alkaline phosphatase as a marker for painful vaso-occlusive events and other acute complications in sickle cell disease
    Han, Jin
    Zhang, Xu
    Shah, Binal N.
    Saraf, Santosh L.
    Gordeuk, Victor R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (02) : 716 - 718
  • [8] A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease
    Rampersaud, Evadnie
    Kang, Guolian
    Palmer, Lance E.
    Rashkin, Sara R.
    Wang, Shuoguo
    Bi, Wenjian
    Alberts, Nicole M.
    Anghelescu, Doralina
    Barton, Martha
    Birch, Kirby
    Boulos, Nidal
    Brandow, Amanda M.
    Brooke, Russell John
    Chang, Ti-Cheng
    Chen, Wenan
    Cheng, Yong
    Ding, Juan
    Easton, John
    Hodges, Jason R.
    Kanne, Celeste K.
    Levy, Shawn
    Mulder, Heather
    Patel, Ashwin P.
    Puri, Latika
    Rosencrance, Celeste
    Rusch, Michael
    Sapkota, Yadav
    Sioson, Edgar
    Sharma, Akshay
    Tang, Xing
    Thrasher, Andrew
    Wang, Winfred
    Yao, Yu
    Yasui, Yutaka
    Yergeau, Donald
    Hankins, Jane S.
    Sheehan, Vivien A.
    Downing, James R.
    Estepp, Jeremie H.
    Zhang, Jinghui
    DeBaun, Michael
    Wu, Gang
    Weiss, Mitchell J.
    [J]. BLOOD ADVANCES, 2021, 5 (14) : 2839 - 2851
  • [9] State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease
    Puri, Latika
    Nottage, Kerri A.
    Hankins, Jane S.
    Anghelescu, Doralina L.
    [J]. PEDIATRIC DRUGS, 2018, 20 (01) : 29 - 42
  • [10] State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease
    Latika Puri
    Kerri A. Nottage
    Jane S. Hankins
    Doralina L. Anghelescu
    [J]. Pediatric Drugs, 2018, 20 : 29 - 42